ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 282,22
-1,51%
Dow Jones
42 732,13
0,80%
DAX
19 906,08
-0,49%
Brent Oil
76,495
0,00%
Bitcoin
97 875,36
-0,34%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) Actualités

LH

Labcorp (LH)

Labcorp Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:LH
DateHeureSourceTitreSymboleSociété
17/12/202413h00PR Newswire (US)Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through PhysiciansNYSE:LHLabcorp Holdings Inc
04/12/202416h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
03/12/202415h11Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
02/12/202422h15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LHLabcorp Holdings Inc
26/11/202414h05PR Newswire (US)Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer PatientsNYSE:LHLabcorp Holdings Inc
19/11/202413h13Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
19/11/202413h00PR Newswire (US)Labcorp CFO Glenn Eisenberg Announces Plans to RetireNYSE:LHLabcorp Holdings Inc
04/11/202415h00Business WirePraia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering ExperienceNYSE:LHLabcorp Holdings Inc
29/10/202416h35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:LHLabcorp Holdings Inc
24/10/202412h50PR Newswire (US)Labcorp Announces 2024 Third Quarter ResultsNYSE:LHLabcorp Holdings Inc
18/10/202420h51Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NYSE:LHLabcorp Holdings Inc
16/10/202414h00Business WireNOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.NYSE:LHLabcorp Holdings Inc
10/10/202414h30PR Newswire (US)Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis TestNYSE:LHLabcorp Holdings Inc
10/10/202412h50PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
24/09/202422h16PR Newswire (US)Labcorp to Announce Third Quarter Financial Results on October 24, 2024NYSE:LHLabcorp Holdings Inc
18/09/202413h00PR Newswire (US)Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum ExperienceNYSE:LHLabcorp Holdings Inc
18/09/202412h12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
17/09/202400h35PR Newswire (US)LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034NYSE:LHLabcorp Holdings Inc
16/09/202423h30Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LHLabcorp Holdings Inc
16/09/202413h30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNYSE:LHLabcorp Holdings Inc
03/09/202422h09PR Newswire (US)Labcorp to Speak at the Baird 2024 Global Healthcare ConferenceNYSE:LHLabcorp Holdings Inc
05/08/202413h00PR Newswire (US)Labcorp Finalizes Acquisition of Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
02/08/202414h30PR Newswire (US)Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus DxNYSE:LHLabcorp Holdings Inc
01/08/202412h57PR Newswire (US)Labcorp Announces 2024 Second Quarter ResultsNYSE:LHLabcorp Holdings Inc
30/07/202413h00PR Newswire (US)Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing CapabilitiesNYSE:LHLabcorp Holdings Inc
01/07/202413h00PR Newswire (US)Labcorp to Announce Second Quarter Financial Results on August 1, 2024NYSE:LHLabcorp Holdings Inc
17/06/202414h00PR Newswire (US)Labcorp Launches Global Trial Connect to Accelerate Clinical TrialsNYSE:LHLabcorp Holdings Inc
03/06/202423h23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NYSE:LHLabcorp Holdings Inc
03/06/202413h00PR Newswire (US)Labcorp Announces New Strategic Service Offerings within Precision Oncology PortfolioNYSE:LHLabcorp Holdings Inc
30/05/202419h18Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
LR
Legrand
NYSE
JPM
JP Morgan Chase
NYSE
DIS
Walt Disney
NASDAQ
GOOGL
Alphabet
COIN
ADAUSD
Cardano
NYSE
KO
Coca Cola
COIN
DOGEUSD
Dogecoin
EU
DG
Vinci
EU
AF
Air FranceKLM
EU
PX1
CAC 40
EU
ORA
Orange
EU
ACA
Credit Agricole
EU
CAP
Capgemini
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés